Friday, May 25, 2018
News Recap:
In Brief:
Liver Stiffness Measurement as a Potential Screening Tool for Liver-Related Events in HCV. The rate of advanced liver fibrosis in community as opposed to urban settings appears to be significant (16.5%) and often underdiagnosed; therefore, liver stiffness measurement is a feasible community screening tool that can be used to predict liver-related events, according to a study published in the Journal of He...
Friday, May 18, 2018
News Recap:
Canada:
Promoting Drug Pricing Policy Resources for Patient Groups. Patient groups in Canada shared in a recent survey that they struggle to understand the complexities of drug pricing policy in Canada and that they would like more information. In response, the Drug Pricing Policy Summit Working Groups have put together two web pages that outline various resources and learning opportunities to help patient groups lea...
Friday, May 11, 2018
News Recap:
HBV:
CADTH recommends that tenofovir alafenamide (TAF) be reimbursed for the treatment of chronic hepatitis B. The CADTH Canadian Drug Expert Committee (CDEC) recommends that tenofovir alafenamide (TAF) be reimbursed for the treatment of chronic hepatitis B in adults with compensated liver disease, if the following condition is met: CONDITION: The drug plan cost of TAF should not exceed that of the lowest-cost prepar...
Friday, April 27, 2018
News Recap:
Warnings:
Synthetic cannabinoids and Hepatitis A could be a fatal combination. On April 9, 2018, the Missouri Department of Health and Senior Services (DHSS) issued a news release – “Use of Synthetic Cannabinoids Linked to Severe Bleeding in the US,” informing the public about the national outbreak of bleeding illnesses among those consuming synthetic cannabinoids which appear to have been contaminated with a long-...
Friday, April 20, 2018
News Recap:
Green tea supplements may cause liver damage, warns EU watchdog. Green tea extracts may cause liver damage, the EU food safety watchdog today announced. Taking more than 800mg of green tea catechins each day may pose health concerns, according to the body's review. Officials were unable to confirm a safe dose.
Race May Affect Ability to Achieve SVR in Hepatitis C. After being treated with direct-acting antiviral...
The Week in Review: March 23, 2018 – April 6, 2018
Friday, April-6-18
News Recap
Focus on Liver Cancer in HCV and HBV patients; HEV Guidelines from EASL; Emricasan clinical trial results, and more....
Read more…http://hepcbc.ca/2018/04/06/the-week-in-review-march-23-april-6-2018/
The Week in Review: March 16, 2018 – March 23, 2018
Friday, March-23-18
News Recap
Northern Vancouver Island Roadshow Slideshows, herbal supplement warnings, tre...
Friday, April 13, 2018
News Recap:
Canada:
Initiative aims to treat Hepatitis C in Alberta patients who also have HIV. A long-term effort to eliminate Hepatitis C as a public health threat is underway in Alberta, where a new program aims to provide medications to one particularly vulnerable group of patients. NOTE: In Alberta, coverage has been expanded as of April 1 to include all patients with hepatitis C. Previously, coverage was provided only to...
Friday, April 6, 2018
News Recap:
HCV – Liver Cancer (HCC):
Liver Cancer on the Rise in Backdrop of Undiagnosed Hep C. Liver cancer, one of the greatest challenges to hepatologists today, will be in the spotlight at the upcoming International Liver Congress (ILC) 2018. It will become an even greater challenge in the near future, said Morris Sherman, PhD, from the University of Toronto, who is chair of the Canadian Liver Foundation.
Testing for he...
Friday, March 23, 2018
News Recap:
Northern Vancouver Island VIRAL HEPATITIS Outreach Roadshow Trip 2018 SlideShow. Our team of volunteers has just return from a week of outreach on Vancouver Island’s north end, and we have put together few slideshows to tell you the story. There will be more images in the next few days, but check out what we have so far! A heartfelt thanks to Cheryl, Leon and Rosemary for doing this.
Novel score predicts DAA ben...
Friday, March 16, 2018
News Recap:
Canada:
Treatment:
Fantastic news from both BC and Quebec this last week: All restrictions to treatment under the respective provincial PharmaCare plans have been removed!! See Chronic hepatitis C medication now available for all British Columbians, and Quebec Expands Patient Access to Chronic Hepatitis C Therapies.
Grants Awarded to 13 Canadian Initiatives to Help Advance the Goal of Eliminating Chronic Hep...
